Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI)

Clinical trial NCT06669273 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06669273
Sponsor: University Hospital, Clermont-Ferrand
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Suspected Prostate Cancer (increased PSA Level)

Start date: 2024-10-01
Primary completion: 2027-06-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.